Richard A. Heyman
Director · 7 filings · Latest: Oct 1, 2026
Enliven Therapeutics, Inc.
Oric Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ELVN | Heyman Richard A. | — | Oct 18, 2024 | Proposed Sale | $28.02 | 12,165 | $340.9K | — | |
ELVN | Heyman Richard A. | — | Oct 15, 2024 | Proposed Sale | $27.75 | 1,270 | $35.2K | — | |
ELVN | Heyman Richard A. | — | Oct 4, 2024 | Proposed Sale | $25.51 | 2,540 | $64.8K | — |
← Previous
Page 2 of 2